Inclusion Criteria:  Have a BMI of greater than or equal to ≥27 kg/m² and <less than 35 kg/m² with at least 2 obesity-related health problems or ≥35 kg/m² with at least 1 obesity-related health problems. Health problems are IGT, hyperlipidemia, or NAFLD. Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight.  Exclusion Criteria:  Have diabetes. Acute or chronic liver disease other than NAFLD. Have a self-reported change in body weight >5 kg within 3 months prior to screening. Have or plan to have endoscopic and/or device-based therapy for obesity or have had device removal within the last 6 months. Have renal impairment measured as estimated glomerular filtration rate (eGFR) <30 mL/min/1.73 m2, calculated by Japanese Society of Nephrology coefficient-modified Chronic Kidney Disease-Epidemiology equation during screening. Have a known clinically significant gastric emptying abnormality. Have had a history of chronic or acute pancreatitis. Have thyroid-stimulating hormone outside of the range of 0.4 to 6.0 micro units per milliliter (μIU/mL) at screening. Have obesity induced by other endocrinologic disorders or diagnosed monogenetic or syndromic forms of obesity. Have a history of significant active or unstable major depressive disorder or other severe psychiatric disorder within the last 2 years. Have a cardiovascular condition within 3 months prior to randomization Have a family or personal history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia Syndrome type 2.